Palantir plummets 18% after Morgan Stanley downgrades company on questionable valuation following massive run

Palantir plummets 18% after Morgan Stanley downgrades company on questionable valuation following massive run
Arnd Wiegmann/Reuters
  • Palantir plummeted as much as 18% on Wednesday after Morgan Stanley downgraded the company to Under-weight from Equal-weight.
  • Palantir has seen a massive rally since it went public in September, surging as much as 235% based on last Friday's high of $33.50.
  • "With very little change in the fundamental story, the risk/reward paradigm shifts decidedly negative for the shares," Morgan Stanley warned.
  • Visit Business Insider's homepage for more stories.

Palantir declined as much as 18% on Wednesday after the high-flying tech firm was downgraded to "Under-weight" by Morgan Stanley.

An "Under-weight" rating is equivalent to a Sell rating on Wall Street. The downgrade came after Morgan Stanley downgraded Palantir to "Equal-weight" from "Over-weight" last month.

Morgan Stanley set a $17 price target for Palantir, representing potential downside of 34% from Tuesday's close.
Advertisement
The driving factor behind Morgan Stanley's downgrade is a heightened valuation for Palantir with very little change to its fundamental story since the company went public in September.

Shares of Palantir have rallied as much as 235% since its September 30 debut, based off of its all time high of $33.50 reached last Friday.

Read more: Zoom has soared 497% this year. 3 analysts — including one of the most accurate in tech — break down whether you should buy, hold, or sell the stock as a vaccine becomes widely available.
Advertisement

"With very little change in the fundamental story, the risk/reward paradigm shifts decidedly negative for the shares," Morgan Stanley warned.

Morgan Stanley isn't alone in its bearish call on Palantir. Last week, famed short-seller Andrew Left of Citron Research called Palantir's rally unsustainable and called the stock a "casino." "What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino," Citron said.
Advertisement

Citron expects Palantir to tumble to $20 by year-end.

Shares of Palantir are down 33% since last week's high, as of Wednesday afternoon trades.

Read more: HSBC says buy these 31 global stocks that are exposed to the pandemic's biggest tech disruptions and set to become growth engines of the future
Advertisement

Palantir plummets 18% after Morgan Stanley downgrades company on questionable valuation following massive run
Markets Insider

{{}}